21 completed, 6 unknown, 3 terminated, 1 not yet recruiting. 31 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 31 | Completed 21, Unknown 6, Terminated 3, Not yet recruiting 1 |
Follow Diabetic Nephropathy: new trials by email Literature Review of Diabetic Nephropathy trials Research Report on Diabetic Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. Ertugliflozin 15 mg - Type 2 Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Completed | Amsterdam UMC, location VUmc | 40 | 2020-12-10 | 2023-05-01 |
| Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes SGLT2 Inhibition - Type 2 Diabetes, Diabetic Nephropathy | Phase 4 | Unknown | Zhongshan Hospital Xiamen University | 70 | 2019-10-15 | 2019-10-21 |
| Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes sodium bicarbonate - Type 1 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | University of Colorado, Denver | 45 | 2017-01-01 | 2026-06-17 |
| CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea Continuous positive airway pressure, Pharmacological treatment, Diet - Diabetic Nephropathy, Sleep Apnea | Phase 4 | Completed | Hospital Universitario La Paz | 180 | 2016-06-01 | 2021-05-11 |
| Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy Lipo-PGE1 - Diabetic Nephropathy | Phase 4 | Completed | West China Hospital | 21 | 2015-12-01 | 2016-12-29 |
| Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes Dapagliflozine 10 mg once daily tablet treatment, Placebo identical once daily tablet treatment - Type 2 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | Peter Rossing | 40 | 2015-08-01 | 2018-09-10 |
| Microalbuminuria and Allopurinol in Type 1 Diabetes Allopurinol, Placebo - Type 1 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | Peter Rossing | 30 | 2014-09-01 | 2018-09-10 |
| Effect of LIXIsenatide on the Renal System Lixisenatide, Insulin glulisine - Diabetic Kidney Disease, Diabetic Nephropathy | Phase 4 | Completed | Amsterdam UMC, location VUmc | 40 | 2014-09-01 | 2016-04-29 |
| Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) Anplag(Sarpogrelate), Placebo - Diabetic Nephropathy | Phase 4 | Completed | Yuhan Corporation | 151 | 2013-02-01 | 2021-04-23 |
| Prevention of Renal Complications of Diabetes With Thiamine Thiamine 300mg PO once daily, placebo - Diabetic Nephropathy | Phase 4 | Unknown | University of Saskatchewan | 40 | 2012-11-01 | 2012-11-12 |
| Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy Calcitriol, Placebo - Diabetic Nephropathy | Phase 4 | Unknown | Seoul National University Hospital | 276 | 2012-10-01 | 2014-02-13 |
| Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Ramipril, Clopidogrel - Diabetes Type 2, Diabetic Nephropathy | Phase 4 | Unknown | AHEPA University Hospital | 60 | 2012-07-01 | 2012-12-06 |
| Renal Denervation in Diabetic Nephropathy Percutaneous renal denervation and TMNS, Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin - Diabetic Nephropathy, Persistent Proteinuria With Type II Diabetes | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 25 | 2012-04-01 | 2016-06-01 |
| Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients intravenous use of sulodexide followed by oral use, use of sulodexide orally only - Diabetic Nephropathy, Albuminuria | Phase 4 | Unknown | Sun Yat-sen University | 80 | 2011-03-01 | 2011-03-16 |
| Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy Paricalcitol - Cardiovascular Disease, Diabetic Nephropathy | Phase 4 | Completed | Peter Rossing | 48 | 2010-04-01 | 2012-04-13 |
| A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy Probucol, Probucol and Cilostazol - Diabetic Nephropathy | Phase 4 | Completed | Otsuka Beijing Research Institute | 353 | 2010-03-01 | 2013-05-08 |
| Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease Aliskiren, Valsartan - Proteinuric Kidney Disease, Diabetic Nephropathy | Phase 4 | Terminated | Columbia University | 46 | 2009-09-01 | 2014-05-15 |
| Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) ACTH - Diabetic Nephropathy, Nephrotic Syndrome | Phase 4 | Completed | Southeast Renal Research Institute | 15 | 2009-05-01 | 2013-05-31 |
| Aldosterone in Diabetic Nephropathy Spironolactone, Placebo - Diabetic Nephropathy | Phase 4 | Unknown | Universidad de los Andes, Chile | 160 | 2009-03-01 | 2009-03-27 |
Showing 20 of 31. Sign in to see all of them.
Diabetic Nephropathies (31) · Diabetes Mellitus, Type 2 (8) · Albuminuria (6) · Diabetes Mellitus (5) · Kidney Diseases (3) · Proteinuria (3) · Diabetes Mellitus, Type 1 (2) · Hypertension (2) · Renal Insufficiency, Chronic (2) · Autoimmune Lymphoproliferative Syndrome, Type IA (1) · Cardiovascular Diseases (1) · Glomerulonephritis, IGA (1) · Glomerulonephritis, Membranous (1) · Glomerulosclerosis, Focal Segmental (1) · Hyperkalemia (1)
Diabetes Complications (31) · Endocrine System Diseases (31) · Female Urogenital Diseases (31) · Female Urogenital Diseases and Pregnancy Complications (31) · Male Urogenital Diseases (31) · Urogenital Diseases (31) · Urologic Diseases (31) · Kidney Diseases (28) · Diabetes Mellitus (26) · Metabolic Diseases (15) · Nutritional and Metabolic Diseases (15) · Glucose Metabolism Disorders (14) · Pathological Conditions, Signs and Symptoms (10) · Signs and Symptoms (9) · Urination Disorders (9)
Ramipril (4) · Valsartan (3) · Hydrochlorothiazide (2) · Lisinopril (2) · Spironolactone (2) · Adrenocorticotropic Hormone (1) · Allopurinol (1) · Alprostadil (1) · Amlodipine (1) · Aspirin (1) · Atenolol (1) · Calcitriol (1) · Cilostazol (1) · Clonidine (1) · Clopidogrel (1)
Peter Rossing (3) · Amsterdam UMC, location VUmc (2) · Gulhane School of Medicine (2) · Steno Diabetes Center Copenhagen (2) · AHEPA University Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · Chen Xiangmei (1) · Columbia University (1) · Fresenius Kabi (1) · Hospital Universitario La Paz (1) · Keryx Biopharmaceuticals (1) · Novartis (1) · Novartis Pharmaceuticals (1) · Otsuka Beijing Research Institute (1) · Seoul National University Hospital (1)
China (6) · Denmark (5) · United States (5) · Netherlands (4) · South Korea (2) · Switzerland (2) · Turkey (Türkiye) (2) · Australia (1) · Canada (1) · Chile (1) · France (1) · Greece (1) · Italy (1) · Spain (1)
D.S Choi, MD, PhD (1) · Dr. Gudrun Caspar-Bell, MD (1) · Edmund J Lewis, MD (1) · Ferdinando C Sasso, MD, PhD (1) · Fotios S Iliadis, Lecturer of Internal Medicine (1) · Francisco Garcia-Rio, MD (1) · G J Navis, MD, PhD (1) · Guillaume Bobrie, MD (1) · H JG Bilo, MD, PhD (1) · Hans-Henrik Parving, MD (1) · Hans-Henrik Parving, MD,DMSc,Prof (1) · Itamar Raz, M.D. (1) · James A. Tumlin, MD (1)
PMID 35224730, PMID 11128341, PMID 16123474, PMID 16316360, PMID 20413516, PMID 22792314, PMID 22995802, PMID 24159603, PMID 25186534, PMID 27733159, PMID 28341782, PMID 28449402, PMID 32340841, PMID 33107592, PMID 34271948, PMID 35998283, PMID 36127497, PMID 36342964, PMID 36344978, PMID 37171199, PMID 38365853, PMID 38449081, PMID 39434255
2009 (1), 2015 (1)